Scarica l'app Stockscreener
6.6495
2.29%
-0.1605
Precedente Chiudi:
$6.81
Aprire:
$6.83
Volume 24 ore:
1.44M
Relative Volume:
0.30
Capitalizzazione di mercato:
$1.21B
Reddito:
$2.51B
Utile/perdita netta:
$-171.15M
Rapporto P/E:
-6.9028
EPS:
-0.9633
Flusso di cassa netto:
$122.59M
1 W Prestazione:
-3.99%
1M Prestazione:
-28.30%
6M Prestazione:
+48.85%
1 anno Prestazione:
-3.15%
Intervallo 1D:
$6.55
$6.83
Intervallo di 1 settimana:
$6.55
$7.235
Portata 52W:
$4.40
$9.8868
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, HQY, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.645 | 1.24B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
237.13 | 38.43B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
59.98 | 11.45B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.65 | 10.05B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
105.55 | 8.83B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
57.69 | 7.62B | 638.78M | -22.66M | 122.18M | -0.1744 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-02-26 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-07-25 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teladoc Health, Inc. (TDOC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Teladoc Health, Inc. (TDOC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Teladoc Health, Inc. Stock 12‑Month Price Target Cut to $7.5, Implies 5% Upside - TradingView
Teladoc Health Inc (TDOC) Stock Analysis & Forecast - TradingKey
Teladoc Health Inc (TDOC) Stock News Today - TradingKey
Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript - AOL.com
Teladoc Health, Inc. (TDOC) options chain - Yahoo Finance Australia
Teladoc Health (TDOC) Securities Investigation NoticeLevi & Korsinsky - Morningstar
Teladoc Health Inc (TDOC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - The AI Journal
Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Investors to Inquire about Securities Investigation - ACCESS Newswire
Director Mark V. Anquillare gets 37,425 RSUs at Teladoc Health (TDOC) - Stock Titan
Teladoc Health (NYSE: TDOC) director Mark Anquillare submits initial Form 3 - Stock Titan
Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 16% Upside Potential Amidst Revenue Challenges - DirectorsTalk Interviews
Teladoc Health, Inc. Announces Appointment of Mark V. Anquillare to its Board of Directors and on the Board?s Audit & Compensation Committees, Effective August 3, 2026 - marketscreener.com
TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Morningstar
Teladoc Health adds former Verisk Analytics exec to board - Investing.com
Teladoc Health (TDOC) Is Down 23.5% After Weak Q2 And Lower 2026 Guidance Has The Bull Case Changed? - Sahm
Teladoc Health Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Teladoc Health Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Teladoc Health (TDOC) - PR Newswire
Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook - TradingView
Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.84, Implies 15% Downside - TradingView
Teladoc Health (NYSE:TDOC) Shares Gap DownHere's What Happened - MarketBeat
Teladoc Health, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2026 - marketscreener.com
Why Teladoc Stock is Getting Crushed Wednesday After Hours - Benzinga
Seeking Clues to Teladoc (TDOC) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
Teladoc (TDOC) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Here's what to expect from Teladoc Health's Q2 print - Seeking Alpha
Discipline and Rules-Based Execution in TDOC Response - Stock Traders Daily
Teladoc Health Launches Person-Centered Virtual Care Platform for Connected Care - HLTH
Teladoc Health Canada Achieves Accreditation Canada Primer Award, Advancing Quality Standards for Virtual and Hybrid Care in Canada - Business Wire
Teladoc Health Inc (TDOC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Teladoc Health Inc (TDOC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TDOC|Teladoc Health Inc|Price:8.770|Chg%:+0.115 - TradingKey
Teladoc Health Inc (TDOC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Teladoc Health Inc (TDOC) Institutional Confidence - TradingKey
Teladoc Health Inc (TDOC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Teladoc Health Inc (TDOC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Teladoc Health Inc (TDOC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AI Tracker: Teladoc launches new virtual care model - Modern Healthcare
TDOC|Teladoc Health Inc|Price:8.911|Chg%:+0.141 - TradingKey
TDOC|Teladoc Health Inc|Price:8.775|Chg%:+0.115 - TradingKey
BofA Securities Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10.5 - Moomoo
Teladoc Health Unveils Outcome-Based Virtual Care Model for Employers and Health Plans - Digital Health News
Is Teladoc Health (TDOC) Undervalued As Teladoc One Tests The AI Health Threat? - Sahm
Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.76, Implies 13% Downside - TradingView
Teladoc, GoodRx shares fall on OpenAI health feature launch - Investing.com
TDOC, AMWL Stocks Retreat After OpenAI Lets Users Link Medical Records To ChatGPT - Stocktwits
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Teladoc Health Inc Azioni (TDOC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Catapano Joseph Ronald | Chief Accounting Officer |
Jul 02 '26 |
Sale |
9.10 |
653 |
5,942 |
12,267 |
1.34%
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):